Literature DB >> 7976272

Interocular blur suppression and monovision.

M J Collins1, A Goode.   

Abstract

The ability of the binocular system to suppress blur from the defocused eye is an important mechanism underlying the success of monovision correction. With a group of 60 new monovision wearers, we found that blur suppression ability varied substantially between subjects and that crossed dominance influenced blur suppression ability. Symptoms of ghosting amongst the monovision wearers appeared to be influenced by the strength of rivalry dominance. An understanding of the suppression processes underlying monovision may assist in patient selection and management.

Entities:  

Mesh:

Year:  1994        PMID: 7976272     DOI: 10.1111/j.1755-3768.1994.tb02777.x

Source DB:  PubMed          Journal:  Acta Ophthalmol (Copenh)        ISSN: 0001-639X


  5 in total

1.  The effect of different monovision contact lens powers on the visual function of emmetropic presbyopic patients (an American Ophthalmological Society thesis).

Authors:  Daniel S Durrie
Journal:  Trans Am Ophthalmol Soc       Date:  2006

2.  A new interocular suppression technique for measuring sensory eye dominance.

Authors:  Eunice Yang; Randolph Blake; James E McDonald
Journal:  Invest Ophthalmol Vis Sci       Date:  2009-07-23       Impact factor: 4.799

3.  Influence of Artificially Generated Interocular Blur Difference on Fusion Stability Under Vergence Stress.

Authors:  Miroslav Dostalek; Karel Fliegel; Ladislav Dusek; Tomas Lukes; Jan Hejda; Michaela Duchackova; Jiri Hozman; Rudolf Autrata
Journal:  J Eye Mov Res       Date:  2019-09-11       Impact factor: 0.957

4.  Crossed versus conventional pseudophakic monovision for high myopic eyes: a prospective, randomized pilot study.

Authors:  Yan Xun; Wenjuan Wan; Lu Jiang; Ke Hu
Journal:  BMC Ophthalmol       Date:  2020-11-16       Impact factor: 2.209

5.  Evaluation of Quality of Vision and Visual Outcomes with Bilateral Implantation of a Non-Diffractive Extended Vision Intraocular Lens with a Target of Slight Myopia in the Non-Dominant Eye.

Authors:  T Hunter Newsom; Richard Potvin
Journal:  Clin Ophthalmol       Date:  2022-01-25
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.